Business Wire

Scientist.com Expands VERIF.i®, its Supplier Pre-assessment Program, to Cover Chemistry, Manufacturing and Controls (CMC)

Share

Scientist.com, the biopharma industry’s leading R&D marketplace, today announced the expansion of VERIF.i, the company’s supplier pre-assessment program, to include Chemistry, Manufacturing and Controls (CMC). CMC suppliers undergo an independent 3rd party pre-assessment, which can then be shared with their entire customer base.

“On-site lab assessments are expensive, time-consuming and labor intensive. VERIF.i alleviates this by enabling an independent 3rd party to confirm that a supplier meets a customer’s research and regulatory requirements,” stated Matt McLoughlin, Sr. VP of Categories & Compliance at Scientist.com. “Pre-assessments help customers speed up supplier selection and purchase highly technical services with more confidence and less risk.”

The pre-assessments performed under VERIF.i are completed with the same independence and objectivity as a study-specific audit but can be applied across multiple clients, saving suppliers time, money and resources. VERIF.i also gives suppliers of regulated research services, such as human biospecimen acquisition—and now chemistry, manufacturing and controls—the opportunity to proactively communicate their quality standards against pre-defined criteria developed with industry partners for use across the biopharma industry.

For more information on VERIF.i, visit https://www.info.scientist.com/verifi

About Scientist.com

Scientist.com’s mission is to empower and connect scientists worldwide. Our digital research platform combines sophisticated AI technology with white-glove Research Concierge® support to enable scientists to run more innovative experiments in less time and at lower cost. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, over 100 biotechnology companies, and the US National Institutes of Health (NIH).

Join Scientist.com on social media: YouTube, LinkedIn, Twitter, Facebook and Instagram.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Sean Preci
marketing@scientist.com
+1 858-815-9274

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Adrestia appoints Will Lewis as Chair, establishes US Operations and appoints new functional leads29.9.2022 14:00:00 EEST | Press release

Adrestia Therapeutics, a leader in synthetic rescue therapies for genetic diseases, today announced that it appointed William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors, Jennifer Millian, M.S., M.B.A. as VP of U.S. Operations, and Philip Coxon, Ph.D., as VP of Business Development. This extends Adrestia’s presence to the United States and deepens its drug development capabilities as it moves its emerging pipeline of first-in-class therapeutics towards the clinic. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220928005044/en/ Will Lewis, Adrestia Chairman “Adrestia’s leading synthetic rescue platform is systematically mining the human genome to find new ways of treating patients with currently intractable diseases” said Lewis. “The team unites world-class biology and drug discovery leadership with an exciting vision for genetic medicine. We are discovering new biology that opens fresh ways of thinking about ta

Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia29.9.2022 13:54:00 EEST | Press release

Fluor Corporation (NYSE: FLR) announced today that the company has been selected by a leading biologics company to perform procurement and construction management for a large-scale biologics drug substance manufacturing facility located in Scandinavia. Fluor will book the multi-hundred-million-dollar reimbursable contract value in the third quarter of 2022. The facility will produce new capacity for advanced biologics that are used in a variety of treatments including vaccines, oncology and quality-of-life medicines. Fluor has performed the planning and enabling work for this project, and construction is now underway with the facility scheduled to be operational by 2025. Fluor’s Advanced Technologies & Life Sciences business is leading the project including support from its Nordic Technology Hub in Copenhagen, Denmark. About Fluor Corporation Fluor Corporation (NYSE: FLR) is building a better future by applying world-class expertise to solve its clients’ greatest challenges. Fluor’s 41

Versace Chooses Board to Transform Retail Planning29.9.2022 13:22:00 EEST | Press release

Board, the leading global provider of Intelligent Planning Solutions which help organizations plan smarter — enabling actionable insights and better outcomes, today announced that Versace, the Italian fashion house that symbolizes luxury worldwide, has chosen Board to transform its Retail Planning. The Versace Group distributes its products through a direct network of over 200 owned boutiques and 1,500 distributors worldwide, with a turnover of more than one billion euros. Due to evolving challenges of global sourcing and the change in consumer purchasing habits, Versace recently revamped its retail strategy by opening new stores, strengthening their multi-channel approach and increasing investments in the efficiency of crucial business planning processes. "Board’s Intelligent Planning platform, provides the flexible and easy to use solutions necessary to support the innovation and growth of our brand,” said Francesco Loporcaro, IT Manager at Versace “Our selection of Board was influen

Satellogic Signs Three-Year Agreement with Government of Albania to Access Dedicated Satellite Constellation29.9.2022 13:00:00 EEST | Press release

Satellogic Inc. (NASDAQ: SATL), a leader in sub-meter resolution Earth Observation (“EO”) data collection, announced today that it has reached a three-year agreement with the Government of Albania to develop a Dedicated Satellite Constellation. This unique program derives from Satellogic’s Constellation-as-a-Service model and will provide Albania with responsive satellite imagery capabilities across its sovereign territory. Satellogic’s unique offering enables municipal, state, and national governments to manage a fleet of satellites over a specific area of interest and develop an EO imaging program at unmatched frequency, resolution, and cost. Satellogic will enable ​​Albania to address pressing issues involving agriculture management, illegal crops, illegal construction activity, traffic management, wildfire monitoring, border security, and environmental monitoring through high-quality imagery with country-wide capacity at a cost-effective price point. Albania will have priority acce

Burjeel Holdings Lights Up Burj Khalifa With New Campaign Featuring Shah Rukh Khan29.9.2022 12:27:00 EEST | Press release

A month ahead of his birthday, Indian actor Shah Rukh Khan lit up the world’s tallest building, The Burj Khalifa, on Wednesday evening, in a brand campaign for the UAE-based conglomerate Burjeel Holdings. For the past few years, on Shah Rukh Khan’s birthday, the Burj Khalifa has lit up in honor of the superstar. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220929005378/en/ The brand campaign of Burjeel Holdings featuring Shah Rukh Khan premiering at Burj Khalifa on Wednesday evening (Photo: AETOSWire) Shah Rukh Khan is the face of the group that owns 39 hospitals and medical centers under the Burjeel, Medeor, LLH, Lifecare, and Tajmeel brands in the UAE and Oman. The campaign, ‘We Are Committed To Your Care’, which is set to appear region-wide on multiple platforms features the Abu Dhabi-headquartered healthcare powerhouse’s homegrown success story. It is based on the group’s vision of connecting care, scale & community in

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom